Sonehara K, Okada Y
Cancer Sci. 2024; 116(2):288-296.
PMID: 39561785
PMC: 11786324.
DOI: 10.1111/cas.16402.
Tian Y, Wu L, Huang C, Wang L
bioRxiv. 2024; .
PMID: 38948854
PMC: 11213234.
DOI: 10.1101/2024.06.19.599704.
Liu H, Chen Q, Guo J, Zhou Y, You Z, Ren J
Brief Bioinform. 2024; 25(3).
PMID: 38546325
PMC: 10976914.
DOI: 10.1093/bib/bbae109.
Zhu Z, Chen X, Zhang S, Yu R, Qi C, Cheng L
Hum Genet. 2023; 142(11):1543-1560.
PMID: 37755483
DOI: 10.1007/s00439-023-02602-9.
Zhong C, Wu C, Lin Y, Lin D
Front Genet. 2023; 14:1180500.
PMID: 37265963
PMC: 10230079.
DOI: 10.3389/fgene.2023.1180500.
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response.
Pagadala M, Sears T, Wu V, Perez-Guijarro E, Kim H, Castro A
Nat Commun. 2023; 14(1):2744.
PMID: 37173324
PMC: 10182072.
DOI: 10.1038/s41467-023-38271-5.
Association of genetic ancestry with HER2, GRB7 AND estrogen receptor expression among Colombian women with breast cancer.
Rey-Vargas L, Bejarano-Rivera L, Mejia-Henao J, Sua L, Bastidas-Andrade J, Ossa C
Front Oncol. 2023; 12:989761.
PMID: 36620598
PMC: 9815522.
DOI: 10.3389/fonc.2022.989761.
DeCAF: a novel method to identify cell-type specific regulatory variants and their role in cancer risk.
Kalita C, Gusev A
Genome Biol. 2022; 23(1):152.
PMID: 35804456
PMC: 9264694.
DOI: 10.1186/s13059-022-02708-9.
Contribution and clinical relevance of germline variation to the cancer transcriptome.
Pereira B, Labrot E, Durand E, Korn J, Kauffmann A, Campbell C
BMC Cancer. 2022; 22(1):675.
PMID: 35725412
PMC: 9208227.
DOI: 10.1186/s12885-022-09757-0.
Allelic imbalance of chromatin accessibility in cancer identifies candidate causal risk variants and their mechanisms.
Grishin D, Gusev A
Nat Genet. 2022; 54(6):837-849.
PMID: 35697866
PMC: 9886437.
DOI: 10.1038/s41588-022-01075-2.
The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal Cancer.
Chan R, Chen P, Yeh Y, Lin B, Yang K, Shen M
Diagnostics (Basel). 2022; 12(2).
PMID: 35204406
PMC: 8871427.
DOI: 10.3390/diagnostics12020315.
Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanisms.
Shetty A, Seo J, Bell C, OConnor E, Pomerantz M, Freedman M
Am J Hum Genet. 2021; 108(11):2071-2085.
PMID: 34699744
PMC: 8595898.
DOI: 10.1016/j.ajhg.2021.09.008.
DeCompress: tissue compartment deconvolution of targeted mRNA expression panels using compressed sensing.
Bhattacharya A, Hamilton A, Troester M, Love M
Nucleic Acids Res. 2021; 49(8):e48.
PMID: 33524140
PMC: 8096278.
DOI: 10.1093/nar/gkab031.
- and -Acting Expression Quantitative Trait Loci of Long Non-Coding RNA in 2,549 Cancers With Potential Clinical and Therapeutic Implications.
Li W, Xu C, Guo J, Liu K, Hu Y, Wu D
Front Oncol. 2020; 10:602104.
PMID: 33194770
PMC: 7604522.
DOI: 10.3389/fonc.2020.602104.
eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene.
Beesley J, Sivakumaran H, Moradi Marjaneh M, Shi W, Hillman K, Kaufmann S
Am J Hum Genet. 2020; 107(4):778-787.
PMID: 32871102
PMC: 7536644.
DOI: 10.1016/j.ajhg.2020.08.006.
Deconvolution of bulk blood eQTL effects into immune cell subpopulations.
Aguirre-Gamboa R, de Klein N, di Tommaso J, Claringbould A, van der Wijst M, de Vries D
BMC Bioinformatics. 2020; 21(1):243.
PMID: 32532224
PMC: 7291428.
DOI: 10.1186/s12859-020-03576-5.
Integrating germline and somatic genetics to identify genes associated with lung cancer.
Pattee J, Zhan X, Xiao G, Pan W
Genet Epidemiol. 2019; 44(3):233-247.
PMID: 31821614
PMC: 7064390.
DOI: 10.1002/gepi.22275.
The Cancer-Associated Genetic Variant Rs3903072 Modulates Immune Cells in the Tumor Microenvironment.
Zhang Y, Manjunath M, Yan J, Baur B, Zhang S, Roy S
Front Genet. 2019; 10:754.
PMID: 31507631
PMC: 6715770.
DOI: 10.3389/fgene.2019.00754.
Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases.
Ng J, Quist J, Grigoriadis A, Malim M, Fraternali F
Nucleic Acids Res. 2019; 47(3):1178-1194.
PMID: 30624727
PMC: 6379723.
DOI: 10.1093/nar/gky1316.
Cancer expression quantitative trait loci (eQTLs) can be determined from heterogeneous tumor gene expression data by modeling variation in tumor purity.
Geeleher P, Nath A, Wang F, Zhang Z, Barbeira A, Fessler J
Genome Biol. 2018; 19(1):130.
PMID: 30205839
PMC: 6131897.
DOI: 10.1186/s13059-018-1507-0.